• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝切特病的流行病学、临床和治疗特征:突尼斯的一项单中心研究。

Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia.

机构信息

Internal Medicine Department, Habib Thameur Hospital, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.

Department of Dermatology, Habib Thameur Hospital, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.

出版信息

Pan Afr Med J. 2021 Sep 3;40:13. doi: 10.11604/pamj.2021.40.13.19146. eCollection 2021.

DOI:10.11604/pamj.2021.40.13.19146
PMID:34733381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8531968/
Abstract

INTRODUCTION

to describe the epidemiological, clinical, therapeutic and evolving characteristics of Behçet´s disease and identify prognostic factors.

METHODS

we have realized a retrospective, single-center study, conducted over a period of 26 years and including 130 patients presenting Behçet´s disease and hospitalized in an Internal Medicine Department.

RESULTS

the mean age of the Behçet´s disease at onset was 30.3 ±8.8 years and that at diagnosis was 34.6 ±9.4 years. The sex ratio (male/female) was 2.5. The mean delay of diagnosis was 53.5 months. Oral aphthosis was constant. The frequency of the manifestations was: genital aphtosis 71.5%, pseudofolliculitis 84.6%, erythema nodosum 11.5%, positive pathergy test 50%, ocular disease 36.9%, venous thrombosis 30%, arterial disease 4.6%, joint damage 30.8%, neurological disease 19.2% and digestive disease 0.8%. The male gender was significantly associated with ocular involvement (p =0.02), venous disease (p =0.01) and occurrence of relapses (p =0.01). The mean follow up was 68.5 ± 77.3 months. The poor survival prognostic factors were male gender, ocular involvement, venous disease, cardiovascular disease, a duration of follow up ≤12 months and a diagnostic delay ≤ 24 months. improving the prognosis of Behçet´s disease requires a shortening of the time to diagnosis, multidisciplinary collaboration, intensive treatment of functional threats, regular monitoring, and patient adherence.

摘要

介绍

描述贝切特病的流行病学、临床、治疗和演变特征,并确定预后因素。

方法

我们进行了一项回顾性、单中心研究,历时 26 年,共纳入 130 例在我院内科住院的贝切特病患者。

结果

贝切特病的发病年龄平均为 30.3 ±8.8 岁,确诊年龄平均为 34.6 ±9.4 岁。男女比例为 2.5。平均诊断延迟时间为 53.5 个月。口腔阿弗他溃疡为常见表现。其他表现的频率如下:生殖器阿弗他溃疡 71.5%、假性毛囊炎 84.6%、结节性红斑 11.5%、帕特试验阳性 50%、眼部疾病 36.9%、静脉血栓形成 30%、动脉疾病 4.6%、关节损伤 30.8%、神经系统疾病 19.2%和消化系统疾病 0.8%。男性与眼部受累(p =0.02)、静脉疾病(p =0.01)和复发(p =0.01)显著相关。平均随访时间为 68.5 ± 77.3 个月。男性、眼部受累、静脉疾病、心血管疾病、随访时间≤12 个月和诊断延迟≤24 个月是预后不良的危险因素。改善贝切特病的预后需要缩短诊断时间、多学科合作、强化对功能威胁的治疗、定期监测和患者的依从性。

相似文献

1
Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia.贝切特病的流行病学、临床和治疗特征:突尼斯的一项单中心研究。
Pan Afr Med J. 2021 Sep 3;40:13. doi: 10.11604/pamj.2021.40.13.19146. eCollection 2021.
2
Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.丝绸之路起点的白塞病:意大利东北部的经验
Acta Dermatovenerol Croat. 2017 Dec;25(4):295-297.
3
Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.白塞病神经表现的特征:突尼斯一项回顾性单中心研究
Clin Neurol Neurosurg. 2013 Oct;115(10):2015-8. doi: 10.1016/j.clineuro.2013.06.009. Epub 2013 Jul 3.
4
[Characteristics of ocular involvement in Behçet disease in Tunisia: Monocentric study and review of literature].[突尼斯白塞病眼部受累的特征:单中心研究及文献综述]
Pathol Biol (Paris). 2015 Apr;63(2):85-90. doi: 10.1016/j.patbio.2014.10.006. Epub 2014 Nov 5.
5
[Behçet's disease in Tunisia. Clinical study of 519 cases].[突尼斯的白塞病。519例临床研究]
Rev Med Interne. 2006 Oct;27(10):742-50. doi: 10.1016/j.revmed.2006.07.019. Epub 2006 Aug 18.
6
Adult Behcet's disease in Iran: analysis of 6075 patients.伊朗成人白塞病:6075例患者分析
Int J Rheum Dis. 2016 Jan;19(1):95-103. doi: 10.1111/1756-185X.12691. Epub 2015 Aug 10.
7
[Behçet's disease in women].[女性白塞病]
Rev Med Interne. 2012 Oct;33(10):552-5. doi: 10.1016/j.revmed.2012.06.007. Epub 2012 Jul 4.
8
Paediatric Behçet's disease in Iran: report of 204 cases.伊朗儿科贝切特病:204 例报告。
Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):135-140. Epub 2018 Jun 19.
9
Behçet disease in Western Algeria.
Med Sante Trop. 2017 Feb 1;27(1):101-104. doi: 10.1684/mst.2017.0656.
10
Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.突尼斯的白塞病。260例患者的人口统计学、临床和遗传学特征
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S58-64.

引用本文的文献

1
Diagnostic delays in systemic vasculitides.系统性血管炎的诊断延误。
Rheumatol Int. 2024 Jun;44(6):1003-1011. doi: 10.1007/s00296-024-05582-9. Epub 2024 Apr 8.
2
Behçet's Disease in Saudi Arabia: Clinical and Demographic Characteristics.沙特阿拉伯的白塞病:临床和人口统计学特征
Cureus. 2023 Feb 11;15(2):e34867. doi: 10.7759/cureus.34867. eCollection 2023 Feb.

本文引用的文献

1
2018 update of the EULAR recommendations for the management of Behçet's syndrome.2018 年更新的欧洲抗风湿病联盟白塞病治疗推荐。
Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.
2
Long-term outcome of neuro-Behçet's disease.神经白塞病的长期转归。
Arthritis Rheumatol. 2014 May;66(5):1306-14. doi: 10.1002/art.38351.
3
[Treatment of Behçet's disease].[白塞病的治疗]
Rev Med Interne. 2014 Feb;35(2):126-38. doi: 10.1016/j.revmed.2013.12.003. Epub 2014 Jan 16.
4
[Cardiovascular involvement in Behçet's disease].[白塞病的心血管受累情况]
Rev Med Interne. 2014 Feb;35(2):103-11. doi: 10.1016/j.revmed.2013.12.002. Epub 2014 Jan 13.
5
[Neurological manifestations of Behçet's disease].[白塞病的神经学表现]
Rev Med Interne. 2014 Feb;35(2):112-20. doi: 10.1016/j.revmed.2013.10.332. Epub 2013 Nov 26.
6
Demographic and clinical features of 521 Turkish patients with Behçet's disease.521例土耳其贝赫切特病患者的人口统计学和临床特征
Int J Dermatol. 2014 May;53(5):564-9. doi: 10.1111/j.1365-4632.2012.05756.x. Epub 2013 Aug 22.
7
Behçet's syndrome: facts and controversies.白塞综合征:事实与争议。
Clin Dermatol. 2013 Jul-Aug;31(4):352-361. doi: 10.1016/j.clindermatol.2013.01.002.
8
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.国际白塞病诊断标准(ICBD):27 个国家对新标准敏感性和特异性的合作研究。
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. doi: 10.1111/jdv.12107. Epub 2013 Feb 26.
9
Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature.白塞病中心脏病变谱:52例患者系列研究及文献综述
Medicine (Baltimore). 2012 Jan;91(1):25-34. doi: 10.1097/MD.0b013e3182428f49.
10
[Behcet syndrome: thirty comments with lung and vascular injury of peripheral vessels].
Presse Med. 2012 Feb;41(2):e52-62. doi: 10.1016/j.lpm.2011.05.018. Epub 2011 Aug 24.